News & Analysis on Clinical Trial Services & Contract Research And Development
Premier Research is expanding its presence in the Asia-Pacific region to include South Korea, Singapore, and Taiwan – with greater health care spending and patient access to new drugs driving demand.
Veristat’s acquisition of Topstone enhances the CRO’s capabilities within several areas and boosts its employee count to 300 across six offices.
Comprehend, a clinical intelligence software company, has packaged its clinical trial risk detection and management service offerings to accommodate the needs of mid-sized CROs.
The pharmaceutical supply services provider Experic has marked its official launch with plans to construct its headquarters at a newly leased Class A research, manufacturing, and packaging facility.
For CDMOs, balancing time, formulation trends, and changing technologies are some of the obstacles on the pathway from formulation to the clinic.
The US FDA approved the first drug created by the 2015 partnership between Regeneron and Sanofi to research and develop immuno-oncology therapies.
Q&A
Ahead of the CPhI Worldwide in Madrid next week, Nemaura announced that it would be showcasing its newly developed 48-hour diclofenac transdermal patch and would be linking up with an unnamed global pharma company to develop three new products.
Bosch packaging technology will showcase its laboratory device for oral solid dosage forms, Xelum R&D for continuous manufacturing.
Specialized capsules and encapsulation techniques can streamline early phase clinical studies – and help researchers meet drug program timelines, says CDMO.
The UK’s MHRA has extended the expiry date of certain batches of Mylan’s EpiPen by four months amid a shortage of supply.
As a relatively small CDMO, Idifarma fits better with small and medium size companies’ goals, costs and flexibility, says executive.